PRP for Patellar Tendinitis
This trial is investigating whether or not platelet-rich plasma is an effective treatment for patellar tendinopathy. Double-blinded means that neither the participants nor the researchers will know who is receiving the treatment until after the study is completed.
- Patellar Tendinitis
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Side effects dataFrom 2020 Phase 4 trial • 70 Patients • NCT02984228
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Are there any restrictions regarding who can enroll in this research project?
"This trial is only open to those between 18 and 39 years old who have tendinitis. A total of 30 patients are needed for this clinical study."
What is the maximum risk that somebody faces when using PRP?
"PRP has undergone some testing for safety, as is common in Phase 2 trials. However, there is no data currently available supporting its efficacy."
Are there any patients that you are currently enrolling for this experiment?
"This particular clinical trial, which was originally announced on April 25th, 2017, is still recruiting patients according to the latest update on July 12th, 2022."
Will this research be testing elderly patients over the age of seventy?
"The age limit for this clinical trial is 18 years or older and 39 years or younger."